Evidence map›Paper›PMID 32586390›Full record

ArticleLipids in health and disease2020

Association between ceramides and coronary artery stenosis in patients with coronary artery disease.

Chenchen Tu, Lan Xie, Zhenjie Wang, Lili Zhang, Hongmei Wu, Wei Ni, Caixia Li, Lin Li, Yong Zeng

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04572191 (Ceramide Level as Apredictor of Outcomes in Patients of Anterior Myocardial Infarction Undergoing Primary Coronary Intervention), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04572191 unknown statusnot on this map

Ceramide Level as Apredictor of Outcomes in Patients of Anterior Myocardial Infarction Undergoing Primary Coronary Intervention

TypeobservationalSponsorAssiut UniversityRan2020 to 2021Enrolled100ConditionsAnterior STEMIArmsCERAMIDE LEVEL IN BLOOD
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Ceramides versus standard methods in prediction of subclinical atherosclerosis.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2026
    Article
  3. The Role of Ceramides in Metabolic and Cardiovascular Diseases.Journal of cardiovascular development and disease · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Observational
  13. Article
  14. Ying and Yang of Ceramide in the Vascular Endothelium.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chenchen TuDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Rd, Chaoyang District, Beijing, 100029, China.
Lan XieBeijing Health Biotech Co. Ltd., yard 7, science park road, Huilongguan, Changping district, Beijing, 102206, China.
Zhenjie WangHealth Examination Center, Peking Union Medical College Hospital, No. 41 Damucang Hutong, Xicheng District, Beijing, 100032, China.
Lili ZhangBeijing Health Biotech Co. Ltd., yard 7, science park road, Huilongguan, Changping district, Beijing, 102206, China.
Hongmei WuBeijing Health Biotech Co. Ltd., yard 7, science park road, Huilongguan, Changping district, Beijing, 102206, China.
Wei NiBeijing Health Biotech Co. Ltd., yard 7, science park road, Huilongguan, Changping district, Beijing, 102206, China.
Caixia LiBeijing Health Biotech Co. Ltd., yard 7, science park road, Huilongguan, Changping district, Beijing, 102206, China.
Lin LiBeijing Health Biotech Co. Ltd., yard 7, science park road, Huilongguan, Changping district, Beijing, 102206, China.
Yong ZengDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Rd, Chaoyang District, Beijing, 100029, China. articlepublish1@126.com.ORCID http://orcid.org/0000-0001-8103-1148
Capital Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

major chronic non-communicable diseases prevention and control research 2018YFC1312801
6 · The paper itself

Abstract

backgroundCoronary artery stenosis induces heart diseases including acute coronary syndrome (ACS). Some studies reported the ceramide species are associated with the ACS and major adverse cardia and cerebrovascular events (MACE). However, few studies investigated the association between plasma ceramide levels and the severity of stenosis, together with the onset of diseases. This aim of the present study was to investigate the association betweencertain ceramide species, coronary artery stenosis and acute coronary syndrome.

methodsFive hundred fifty-three patients with definite or suspected CAD were recruited and received angiography. Subjects were assigned into 4 groups according to the severity of coronary artery stenosis. The measurements of 4 plasma ceramide species, namely, Cer (d18:1/16:0), Cer (d18:1/18:0), Cer (d18:1/24:1), Cer (d18:1/24:0) were carried out by Liquid chromatography-tandem mass spectrometry (LC-MS/MS) and the ratio of Cer (d18:1/16:0), Cer (d18:1/18:0) and Cer (d18:1/24:1) to Cer (18:1/24:0), respectively, were calculated as index to evaluate the association between plasma ceramides levels and coronary artery stenosis. Multiple logistic regression analysis was used to establish the prognostic model for the prediction of ACS risk.

resultsAfter the adjustment by multiple clinical risk factors including age, gender, pre-existing myocardial/cerebral infarction, hemoglobin A1c% (HbA1c%), smoking and the diagnosis during index hospitalization, multiple logistic regression analysis showed that the high ratio of Cer (d18:1/24:1) to Cer (d18:1/24:0), female gender, HbA1c%, unstable angina (UAP) and acute myocardial infarction (AMI) diagnosis (compared with atherosclerosis) during index hospitalization were associated with more severe coronary artery stenosis. Furthermore, the prognostic model was established after adjustment of risk factors and the area under curve (AUC) of receiver operating characteristics (ROC) for the prognostic model was 0.732 and 95% CI was 0.642-0.822.

conclusionThe severity of coronary artery stenosis is associated with high ratio of Cer (d18:1/24:1) to Cer (d18:1/24:0), female gender, HbA1c% and AMI. Although the reported prognostic model showed a good discrimination, further investigation on long term MACE is needed to evaluate the role of ceramide for the prediction of MACE risk.

Indexed as

AgedCardiovascular DiseasesCeramidesCoronary AngiographyCoronary Artery DiseaseCoronary StenosisFemaleGlycated HemoglobinHumansIncidenceMaleMiddle AgedMyocardial InfarctionPrognosisRisk FactorsROC CurveCeramidesGlycated Hemoglobinhemoglobin A1c protein, humanAcute coronary syndromeAcute myocardial infarctionCeramideCoronary stenosisLiquid chromatography-tandem mass spectrometryMajor adverse cardiac and cerebrovascular events

Identifiers

PMID32586390
PMCPMC7315545
OpenAlexW3037797296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.